OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Treatment of delta hepatitis
Fulya Günşar
Expert Review of Anti-infective Therapy (2013) Vol. 11, Iss. 5, pp. 489-498
Closed Access | Times Cited: 12
Fulya Günşar
Expert Review of Anti-infective Therapy (2013) Vol. 11, Iss. 5, pp. 489-498
Closed Access | Times Cited: 12
Showing 12 citing articles:
Global strategies are required to cure and eliminate HBV infection
Peter Revill, Barbara Testoni, Stephen Locarnini, et al.
Nature Reviews Gastroenterology & Hepatology (2016) Vol. 13, Iss. 4, pp. 239-248
Closed Access | Times Cited: 149
Peter Revill, Barbara Testoni, Stephen Locarnini, et al.
Nature Reviews Gastroenterology & Hepatology (2016) Vol. 13, Iss. 4, pp. 239-248
Closed Access | Times Cited: 149
Hepatitis Delta Is a Major Determinant of Liver Decompensation Events and Death in HIV-Infected Patients
José Vicente Fernández-Montero, Eugenia Vispo, Pablo Barreiro, et al.
Clinical Infectious Diseases (2014) Vol. 58, Iss. 11, pp. 1549-1553
Open Access | Times Cited: 94
José Vicente Fernández-Montero, Eugenia Vispo, Pablo Barreiro, et al.
Clinical Infectious Diseases (2014) Vol. 58, Iss. 11, pp. 1549-1553
Open Access | Times Cited: 94
Drugs in Development for Hepatitis B
Altaf Dawood, Syed Abdul Basit, Mahendran Jayaraj, et al.
Drugs (2017) Vol. 77, Iss. 12, pp. 1263-1280
Open Access | Times Cited: 32
Altaf Dawood, Syed Abdul Basit, Mahendran Jayaraj, et al.
Drugs (2017) Vol. 77, Iss. 12, pp. 1263-1280
Open Access | Times Cited: 32
Prenylation of viral proteins by enzymes of the host: Virus‐driven rationale for therapy with statins and FT/GGT1 inhibitors
Е. С. Маракасова, Birgit Eisenhaber, Sebastian Maurer‐Stroh, et al.
BioEssays (2017) Vol. 39, Iss. 10
Open Access | Times Cited: 26
Е. С. Маракасова, Birgit Eisenhaber, Sebastian Maurer‐Stroh, et al.
BioEssays (2017) Vol. 39, Iss. 10
Open Access | Times Cited: 26
Hepatitis B and D Viruses
Rebecca T. Horvat, Ryan M. Taylor
ASM Press eBooks (2015), pp. 1841-1858
Closed Access | Times Cited: 22
Rebecca T. Horvat, Ryan M. Taylor
ASM Press eBooks (2015), pp. 1841-1858
Closed Access | Times Cited: 22
Pegylated Interferon α Therapy in Chronic Delta Hepatitis: A One-Center Experience
Ibrahim Halil Bahçecıoğlu, Murat İspiroğlu, Ulvi Demirel, et al.
Hepatitis Monthly (2015) Vol. 15, Iss. 3
Open Access | Times Cited: 19
Ibrahim Halil Bahçecıoğlu, Murat İspiroğlu, Ulvi Demirel, et al.
Hepatitis Monthly (2015) Vol. 15, Iss. 3
Open Access | Times Cited: 19
Drug–Drug Interaction Potential of the HBV and HDV Entry Inhibitor Myrcludex B Assessed in vitro
Antje Blank, Katrin Meier, Stephan Urban, et al.
Antiviral Therapy (2017) Vol. 23, Iss. 3, pp. 267-275
Closed Access | Times Cited: 14
Antje Blank, Katrin Meier, Stephan Urban, et al.
Antiviral Therapy (2017) Vol. 23, Iss. 3, pp. 267-275
Closed Access | Times Cited: 14
Prokaryotic Expression, Purification and Immunogenicity in Rabbits of the Small Antigen of Hepatitis Delta Virus
V. L. Tunitskaya, Olesja Eliseeva, Vladimir T. Valuev-Elliston, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 10, pp. 1721-1721
Open Access | Times Cited: 8
V. L. Tunitskaya, Olesja Eliseeva, Vladimir T. Valuev-Elliston, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 10, pp. 1721-1721
Open Access | Times Cited: 8
The FNTB promoter polymorphism rs11623866 as a potential predictive biomarker for lonafarnib treatment of ovarian cancer patients
Hagen S. Bachmann, Werner Meier, Andreas du Bois, et al.
British Journal of Clinical Pharmacology (2015) Vol. 80, Iss. 5, pp. 1139-1148
Open Access | Times Cited: 6
Hagen S. Bachmann, Werner Meier, Andreas du Bois, et al.
British Journal of Clinical Pharmacology (2015) Vol. 80, Iss. 5, pp. 1139-1148
Open Access | Times Cited: 6
Letter: the potential success of long-term therapy of chronic delta hepatitis with peginterferon alfa
Alberto Enrico Maraolo, Fausto Minervini, Grazia Tosone
Alimentary Pharmacology & Therapeutics (2015) Vol. 41, Iss. 6, pp. 595-595
Open Access | Times Cited: 2
Alberto Enrico Maraolo, Fausto Minervini, Grazia Tosone
Alimentary Pharmacology & Therapeutics (2015) Vol. 41, Iss. 6, pp. 595-595
Open Access | Times Cited: 2
Can We Predict Sustained Virologic Response to Interferon α Therapy in Patients With Chronic Hepatitis Delta Virus Infection?
Caroline Scholtès, Rajneesh Kumar, Fabien Zoulim
Clinical Gastroenterology and Hepatology (2015) Vol. 13, Iss. 13, pp. 2350-2352
Open Access | Times Cited: 1
Caroline Scholtès, Rajneesh Kumar, Fabien Zoulim
Clinical Gastroenterology and Hepatology (2015) Vol. 13, Iss. 13, pp. 2350-2352
Open Access | Times Cited: 1
Letter: cure of chronic hepatitis B and D after 12 years of treatment with low‐dose standard interferon alfa‐2b
Э З Бурневич, Sergey Moiseev, Н А Мухин
Alimentary Pharmacology & Therapeutics (2016) Vol. 44, Iss. 6, pp. 649-650
Open Access | Times Cited: 1
Э З Бурневич, Sergey Moiseev, Н А Мухин
Alimentary Pharmacology & Therapeutics (2016) Vol. 44, Iss. 6, pp. 649-650
Open Access | Times Cited: 1
